Melanoma Clinical Trial Success Story: From Patient Volunteer to No Evidence of Disease

By Renee Orcione, MRA Development Associate | 3 August 2022 In Melanoma Stories, Science

This Mom of three enrolled in a neoadjuvant clinical trial for Stage 3 melanoma. After two infusions of Opdualag, Shannon underwent a successful surgery where doctors removed all affected lymph nodes and tested them, revealing No Evidence of Disease (NED).

Read More


What Uveal Melanoma Patients Need to Know about KIMMTRAK

By Cody Barnett, MPH, MRA Director of Communications & Patient Engagement | 18 July 2022 In Science, Treatment

You may have heard of KIMMTRAK, a new therapy that recently earned FDA approval for the treatment of metastatic or unresectable uveal melanoma. Uveal melanoma, also called ocular melanoma, is a rare melanoma subtype that affects about 2,500 people each year in the United States. KIMMTRAK is the first drug to earn FDA approval to treat these patients.

Read More


New Funding Alert: Department of Defense Melanoma Research Program

1 July 2022 In Allies & Partnerships, News, Science

Research Funding Alert: The Department of Defense Melanoma Research Program will award up to $40 million in funding for melanoma research in FY22. Learn more about funding mechanisms, focus area, and deadlines!

Read More


This Mother-Daughter Duo Are On a Mission to Save Your Skin

By Cody Barnett, MPH, MRA Director of Communications & Patient Engagement | 27 June 2022 In Allies & Partnerships, Prevention

Dr. Beth and Elianna Goldstein aren’t your usual mother-daughter duo. That’s because they are just as comfortable heading to yoga together as they are reviewing quarterly sales projections for their startup, Modern Ritual. The company, launched in 2020, creates simple and effective skin care products and services to protect you...

Read More


25-Year-Old Melanoma Patient Runs Marathon to Support Research

By Renee Orcione, MRA Development Associate | 24 June 2022 In Melanoma Stories

Camille Price was 24-years old when she was diagnosed with Stage 3 Melanoma. After undergoing surgery and an additional treatment to reduce the likelihood of her melanoma returning, she chose to run the Miami Marathon in support of the Melanoma Research Alliance.

Read More


Preventing Melanomas Before they Happen in Oregon Schools

By Cody Barnett, MPH, MRA Director of Communications & Patient Engagement | 22 June 2022 In Prevention, Science

Dr. Haag and his team had an ambitious goal: they wanted the melanoma prevention and early detection curriculum taught in every high school throughout the state of Oregon. Their curriculum has now been taught to 10,653 students across 79 high schools throughout Oregon.

Read More


Leveraged Finance & Private Equity Communities Unite to Raise Record $3 Million for Melanoma Research

21 June 2022 In Allies & Partnerships, Events, News, Prevention

On Thursday, June 16, 2022, more than 900 people from over 100 firms from the leveraged finance and private equity communities came together for the Leveraged Finance Fights Melanoma (LFFM) benefit and cocktail party. Hosted at the Museum of Modern Art, the event raised a record breaking $3 million for the Melanoma Research Alliance’s (MRA) mission to advance the world’s most innovative and promising melanoma research.

Read More


Don’t Fry Day: Today & Everyday

27 May 2022 In Allies & Partnerships, Events

Each year the National Council on Skin Cancer Prevention designates the Friday before Memorial Day as Don’t Fry Day to raise awareness of the importance of sun safety. This year’s theme, Small Steps for Sun Safety, highlights the many small steps we can take to be more sun safe, like...

Read More


What Melanoma Patients Need to Know about Opdualag

By Cody Barnett, MPH, MRA Director of Communications & Patient Engagement | 23 May 2022 In Science, Treatment

You may have heard of Opdualag, a new therapy that recently earned FDA approval for advanced melanoma. Opdualag, which combines two different immunotherapies into one medicine, is earning attention as an effective – and more easily tolerated – combination therapy.

Read More


MRA Announces $13 Million in Grants to Advance Melanoma Prevention, Detection & Treatment

By Cody Barnett, MPH, MRA Director of Communications & Patient Engagement | 19 May 2022 In News, Prevention, Science, Treatment

Coinciding with Melanoma Awareness Month, the Melanoma Research Alliance (MRA), the largest non-profit funder of melanoma research, today announced funding for 27 research grants totaling $13,046,774 to support new research aimed at advancing melanoma prevention, diagnosis and treatment.

Read More


Login

×